Empowered Patient Podcast

Cathy Kuhn PharmD, Director of Strategy Consulting, Updox has a deep understanding of the communications needs of pharmacists, healthcare providers, and patients and what issues can be addressed by moving from paper to digital. Updox is creating a secure virtual care online environment to encourage the reduction of reliance on paper forms and faxes, a shift which is gaining more wide-spread acceptance particularly in the age of COVID-19. @Updox #pharmacists #Pharmacy #PharmacistsProvideCare #digitalhealth #telehealth #COVID19 Updox.com Download the transcript here

Daniel O'Connor, CEO, OncoSec Immunotherapies describes their intratumoral therapy where the drug is injected directly into tumors instead of a systemic treatment thereby avoiding toxicities while also seeing tumors shrink that are not being directly treated, the abscopal effect. OncoSec is using electroporation to deliver interleukin-12 into cells. IL-12 is considered to be one of the most potent cytokines to fight cancer and their drug TAVO is being tested in conjunction with KEYTRUDA to help patients with melanoma not responding to current treatments. @oncosec #oncology #cancer #interleukin-12 #IL-12 #melanoma #breastcancer #TAVO #immunotherapy $ONCS OncoSec.com Download the transcript here

Dr. Bill Audeh, medical oncologist and Chief Medical Officer, Agendia left his 30 year career of medical practice treating breast cancer patients to join Agendia because of the exciting opportunities for precision medicine to treat breast cancer. With technology that allows for genomic testing of the cancer tumors, it can be determined how likely it is that the cancer could spread and identifies what's driving the cancer's growth.  With this data, physicians can be informed about the best treatment for each individual patient. @agendia #precisionmedicine #genomictesting #breastcancer Agendia.com Download the transcript here

Catherine Rivier, Co-Founder Sentia Medical is an expert on stressors and the impact physical, emotional, and infectious or inflammatory stressors have on the brain and the body. Her research along with her late husband at the Salk Institute in San Diego led to the discovery of the main stress hormone CRF. Sentia is now developing astressins - compounds that will counter some of the effects of stressor on the body.  Their focus is treating irritable bowel syndrome, a key stressor-induced gastrointestinal disease. #SentiaMedical #IBS #CRF #stressors SentiaMedical.com Download the transcript here

Tara Davis Director of Community Health, Rimidi has deep expertise in the development and evaluation of public health prevention programs. She explains why it has become exponentially more difficult to ensure minorities, low income, rural and patients living with chronic conditions to receive even basic care they need as a result of being disproportionately affected by COVID-19. Tara emphasizes the essential role technology must play in enabling data-driven healthcare and how the expanding use of mobile devices is leading to more opportunities to help vulnerable populations who need care. #COVID19 #digitalhealth #telehealth Rimidi.com Download the transcript here

Dr. Sheri Prentiss, physician and founder LIVE Today Foundation and Rick Carreon, CEO and President, Impedimed are excited about their partnership to raise awareness about early diagnosis and treatment of lymphedema to prevent it from becoming a chronic condition. The Impedimed device conducts a simple and fast test to detect small fluid shifts of lymphatic fluid building. Results alert doctors about the presence of lymphedema allowing them to stop the progression or reverse it.  Working together, Sheri and Rick are educating clinicians and patients about this life changing approach for five and a half million cancer survivors living with lymphedema in the US today. @LIVETodayDotOrg. @Impedimed #lymphedema #breastcancer LIVE-today.org Impedimed.com Download the transcript here.

Christian Pierret, former French Minister of Industry and member of the board of different biotech and MedTech European companies gives a report on the recent in-person and virtual HealthTech Innovation Days held in Paris in October 2020.  Now in it's second year, HTID attracted international participants, global pharmaceutical companies, and investors in life sciences, MedTech, biotech and digital technology. COVID-19 is not only a crisis for this community but a challenge to invent and create new R&D to breakthrough the current landscape. @HTID_Paris #HTID #HealthTechInnovationDays #healthcare #COVID19 HTDI-Paris.com Download the transcript here

Greg Hammer MD is a pediatric intensive care physician, pediatric anesthesiologist, Stanford University Medical Center professor, student of Buddhism and author of GAIN Without Pain: The Happiness Handbook for Health Care Professionals.  Greg talks about the impact of chronic stress and the wide variety of stressors affecting health care workers as well as those isolated at home.  He also introduces the four pillars of his GAIN strategy-- gratitude, acceptance, intention and non-judgment-- and how he incorporates these principles into his own life. @greghammerMD #COVID19 GregHammerMD.com Download the transcript here

Dr. Kevin de la Roza is a pediatric cardiac anesthesiologist and entrepreneur who has developed the Vocera Ease app that allows for care team members and family to stay in touch during the hospitalization of a patient.  Especially in the time of COVID-19 and changes in access to the waiting room, this app is a valuable one-way communications tool so that nurses and doctors can share real-time updates and videos and initiate a video chat with family members to keep them aware of progress while their loved one is in the hospital. @VoceraEase. @Vocera #COVID19 Vocera.com Download the transcript here.

Cam Deemer, President, DrFirst shines light on the world of drug pricing and the lack of cost transparency for both doctors and patients. DrFirst is working with Prime Therapeutics, a PBM primarily focused on BlueCross and BlueShield, to integrate their data and provide drug price transparency to now 90% of covered lives. Cost is the number one reason people do not fill a prescription and patients are more likely to abandon an expensive prescription. Doctors and patients need to have an informed conversation about costs of therapy versus benefits of a particular drug. @DrFirst  #pricetransparency #medadherence #medicaladherence DrFirst.com Download the transcript here